title: E07_Bl001_Cross4770

description:
DNA extracted from single blastomere derived from cleavage stage IVM-IVF embryo of pedigree 4770 and subsequently whole genome amplified by Repli-G Single cell kit according to manufacturer's 3h protocol.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: E07_Bl003_Cross4770

status: Public on Sep 24 2017

type: genomic

city: Maastricht

first: Masoud

last: Zamani Esteki

state: Limburg

address: P. Debyelaan 25

department: Clinical Genetics

country: Netherlands

institute: Maastricht University Medical Center

description:
DNA extracted from single blastomere derived from cleavage stage IVM-IVF embryo of pedigree 4770 and subsequently whole genome amplified by Repli-G Single cell kit according to manufacturer's 3h protocol
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).

hyb_protocol: According to the manual of Infinium II Assay (Illumina, USA).

scan_protocol: The scanning of the bead-chips was performed on an iScan, using the iScan Control software (Illumina, USA)

data_processing: The genotypes, B allele frequencies and LogR values were processed by the Genotyping module of GenomeStudio software. The discrete genotypes were determined using a threshold of 0,75. We subsequently fed these data into siCHILD algorithm, which is equipted with haplarithmisis (Zamani Esteki et al. 2015, AJHG).

molecule: genomic DNA

organism: Bos taurus

source_name: Blastomere

label_protocol: The samples were not labelled before the hybridization. The staining is based on post-hybridization Cy5/Cy3 labelling by extension, according to the manual of Infinium II Assay (Illumina, USA).

growth_protocol: The zygotes of IVM-IVF and OPU-IVF embryos were transferred to synthetic oviductal fluid (SOF) supplemented with essential and non-essential amino acids (SOFaa), 0.4% BSA and ITS (5 µg/ml insulin, 5 µg/ml transferrin and 5 ng/ml selenium). In vitro culture (IVC) occurred in 4-well dishes in 20 µL drops (1 per donor cow) covered with mineral oil. Embryos were incubated at 38.5°C in 5% CO2, 5% O2 and 90% N2. In vivo derived embryos were obtained by flushing of the oviduct

extract_protocol: The isolated blastomeres were placed immediately on dry ice and stored in -20oC for 30 minutes prior to whole genome amplification (WGA). WGA was performed on the day of blastomere isolation. DNA from single blastomeres was whole-genome amplified using commercial MDA kit (REPLI-g Single Cell Kit, Qiagen). MDA amplification of single blastomeres with the single-cell Repli-g kit was performed according to the manufacturer’s instructions for the fast 3-hour protocol. WGA products were purified using SPRI-beads (AMPure) at 0.8x of total reaction volume.

treatment_protocol: The embryos were treated with pronase to dissolve the zona pellucida (0.1% protease from S. griseus, P88110, Sigma-Aldrich in TCM-199 for IVM-IVF and OPU-IVF embryos and 1% for in vivo derived embryos) and were subsequently washed in TCM-199 with 10% FBS followed by Ca+2/Mg+2 free PBS with 0.05% BSA to stimulate blastomere dissociation. Subsequently, the zona-free embryos were washed in Ca+2/ Mg+2 free PBS with 0.1% PVP (wash medium) and were transferred onto a petri dish for blastomere dissociation. Blastomere pick-up and tubing was performed with the use of a mouth-pipetting system using a 75μm capillary.

tag: cell type

value: Blastomere

tag: dna sample

value: Single Cell

tag: wga

value: MDA (Repli-G Single Cell kit)


title: E07_Bl006_Cross4770


title: E08_Bl001_Cross4770


title: E04_Bl002_Cross4770

description:
DNA extracted from single blastomere derived from cleavage stage in vivo derived embryo of pedigree 4770 and subsequently whole genome amplified by Repli-G Single cell kit according to manufacturer's 3h protocol.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: E07_Bl002_Cross4770


title: E07_Bl004_Cross4770


title: E07_Bl005_Cross4770


title: E04_Bl003_Cross4770


title: E03_Bl005_Cross4770

description:
DNA extracted from single blastomere derived from cleavage stage OPU-IVF embryo of pedigree 4770 and subsequently whole genome amplified by Repli-G Single cell kit according to manufacturer's 3h protocol.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: E03_Bl001_Cross4770


title: E05_Bl001_Cross4770


title: E02_Bl008_Cross4770


title: E02_Bl007_Cross4770


title: E03_Bl003_Cross4770


title: E02_Bl006_Cross4770


title: E03_Bl004_Cross4770


title: E08_Bl002_Cross4770


title: E02_Bl002_Cross4770


title: E02_Bl004_Cross4770


title: E02_Bl003_Cross4770


title: E01_Bl004_Cross4770


title: E02_Bl001_Cross4770


title: E02_Bl005_Cross4770


title: E01_Bl003_Cross4770


title: E01_Bl002_Cross4770


title: E07_Bl004_Cross4006

description:
DNA extracted from single blastomere derived from cleavage stage IVM-IVF derived embryo of pedigree 4006 and subsequently whole genome amplified by Repli-G Single cell kit according to manufacturer's 3h protocol.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: E04_Bl001_Cross4770


title: E05_Bl002_Cross4770


title: E07_Bl005_Cross4006


title: E01_Bl001_Cross4770


title: E07_Bl006_Cross4006


title: E06_Bl007_Cross4006


title: E06_Bl005_Cross4006


title: E07_Bl003_Cross4006


title: E03_Bl002_Cross4770


title: E06_Bl002_Cross4006


title: E07_Bl001_Cross4006


title: E06_Bl006_Cross4006


title: E07_Bl002_Cross4006


title: E06_Bl003_Cross4006


title: E06_Bl004_Cross4006


title: PMA_1h_2

city: Rehovot

first: Yehoshua

last: Enuka

address: Herzl 234

department: Biological Regulation

country: Israel

institute: Weizmann Institute of Science

hyb_protocol: bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation450 Beadchip using standard Illumina protocol

scan_protocol: Arrays were imaged using BeadArray Reader using standard recommended Illumina scanner setting

data_processing:
CpG methylation analysis using Illumina 450K Bead Arrays was performed by Genome Quebec. DNA methylation was measured using the Minfi package in-R (Aryee et al., 2014) with the SWAN normalization method. Probes whose total intensity was less than 5000 were excluded.
A summary of beta values following the different treatments

label: Cy5 and Cy3

organism: Homo sapiens

label_protocol: Standard Illumina Protocol

extract_protocol: Genomic DNA from triplicate samples was harvested by first washing the plates with cell lysis solution (0.25% Triton X-100, 20 µg/ml RNase H, 10 mM Tris pH 8.0, 1 mM EDTA). Thereafter, nuclei were washed (200 mM NaCl, 20 µg/ml RNase H, 10 mM Tris pH 8.0, 1mM EDTA), prior to lysis with nuclear lysis buffer (0.5% SDS, 200 mM NaCl, 20 µg/ml RNase H, 10 mM Tris pH 8.0, 1mM EDTA). The nuclear lysate was incubated at 37°C for 1 hour. Proteinase K was added to 100 µg/ml and the samples were incubated overnight at 55°C. On the next day the samples were extracted twice using phenol-chloroform-isoamyl alcohol (PCIA, 25:24:1, pH 8.0, from Sigma) and washed twice with chloroform, prior to ethanol precipitation. The pellet was re-suspended in TE (10 mM Tris pH 8.0, 1 mM EDTA).

tag: treatment

value: PMA

tag: time


title: PMA_1h_3


title: E06_Bl001_Cross4006


title: E05_Bl002_Cross4006

description:
DNA extracted from single blastomere derived from cleavage stage in vivo derived embryo of pedigree 4006 and subsequently whole genome amplified by Repli-G Single cell kit according to manufacturer's 3h protocol.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: E05_Bl001_Cross4006


title: PMA_1h_1


title: E04_Bl001_Cross4006


title: Mother_Cross4006

description:
DNA extracted from a large amount of cells derived from the cow's blood using DNeasy Blood and Tissue kit (Qiagen). Used for embryo production in pedigree 4006.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).

source_name: Blood

value: Blood

value: Multi cell


title: E02_Bl002_Cross4006

description:
DNA extracted from single blastomere derived from cleavage stage OPU-IVF embryo of pedigree 4006 and subsequently whole genome amplified by Repli-G Single cell kit according to manufacturer's 3h protocol.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: E02_Bl004_Cross4006


title: E04_Bl002_Cross4006


title: EGF_4h_1

value: EGF


title: EGF_1h_3


title: EGF_4h_3


title: E03_Bl002_Cross4006


title: E03_Bl001_Cross4006


title: EGF_4h_2


title: E02_Bl003_Cross4006


title: DOX_1h_3

value: DOX


title: E06_Bl008_Cross4006


title: EGF_1h_2


title: DOX_1h_2


title: E04_Bl003_Cross4006


title: EGF_1h_1


title: DOX_1h_1


title: E01_Bl006_Cross4006


title: DEX_1h_2

value: DEX


title: E02_Bl001_Cross4006


title: DEX_1h_3


title: E01_Bl003_Cross4006


title: DEX_1h_1


title: DMSO_1h_3

value: DMSO


title: E01_Bl001_Cross4006


title: E01_Bl002_Cross4006


title: E01_Bl004_Cross4006


title: E01_Bl005_Cross4006


title: e480_3

data_processing: CpG methylation analysis using Illumina 450K Bead Arrays was performed by Genome Quebec. DNA methylation was measured using the Minfi package in-R (Aryee et al., 2014) with the SWAN normalization method. Probes whose total intensity was less than 5000 were excluded.

tag: cell line

tag: sample groupd


title: MaternalGrandfather_Cross4757

description:
DNA extracted from a large amount of cells derived from the bull's semen using DNeasy Blood and Tissue kit (Qiagen). Used for subsequent computational workflow and embryo analysis in pedigree 4757.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).

source_name: Semen

value: Semen


title: DMSO_1h_2


title: DMSO_1h_1


title: e480_1


title: e480_2


title: e240_3


title: PaternalGrandfather

description:
DNA extracted from a large amount of cells derived from the bull's semen using DNeasy Blood and Tissue kit (Qiagen). Used for subsequent computational workflow and embryo analysis in pedigrees 4757, 4770, 4006, 8301 and 9617.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: MaternalGrandmother_Cross4757

description:
DNA extracted from a large amount of cells derived from the cow's blood using DNeasy Blood and Tissue kit (Qiagen).  Used for subsequent computational workflow and embryo analysis in pedigree 4757.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: Mother_Cross4757

description:
DNA extracted from a large amount of cells derived from the cow's blood using DNeasy Blood and Tissue kit (Qiagen). Used for embryo production in pedigree 4757.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: e240_1


title: e240_2


title: E05_Bl005_Cross4757

description:
DNA extracted from single blastomere derived from cleavage stage IVM-IVF embryo of pedigree 4757 and subsequently whole genome amplified by Repli-G Single cell kit according to manufacturer's 3h protocol.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: e120_3


title: e120_2


title: PaternalGrandmother

description:
DNA extracted from a large amount of cells derived from the cow's blood using DNeasy Blood and Tissue kit (Qiagen).  Used for subsequent computational workflow and embryo analysis in pedigrees 4757, 4770, 4006, 8301 and 9617.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: Father

description:
DNA extracted from a large amount of cells derived from the bull's semen using DNeasy Blood and Tissue kit (Qiagen). Used for embryo production and computational workflow in pedigrees 4757, 4770, 4006, 8301 and 9617.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: E05_Bl004_Cross4757


title: e060_2


title: E05_Bl003_Cross4757


title: e120_1


title: E05_Bl002_Cross4757


title: e060_1


title: e060_3


title: E03_Bl004_Cross4757

description:
DNA extracted from single blastomere derived from cleavage stage OPU-IVF embryo of pedigree 4757 and subsequently whole genome amplified by Repli-G Single cell kit according to manufacturer's 3h protocol.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: E04_Bl003_Cross4757


title: E04_Bl002_Cross4757


title: e040_2


title: e040_3


title: unstimulated_t0.5_4

status: Public on Sep 23 2017

type: RNA

city: Giessen

first: Jochen

last: Wilhelm

state: Hessen

address: Aulweg 132

department: Institute for Lung Health

country: Germany

institute: Justus-Liebig University Giessen

description:
Array 51 Cy5
Raw data in cy5 channel of: 251486831975_0004.gpr

hyb_protocol: Cy3- and Cy5-labeled RNAs were hybridized overnight to 4×44K 60mer oligonucleotide spotted microarray slides (Mouse Whole Genome 4×44K; Agilent Technologies, P/N G4122F). Hybridization and subsequent washing and drying of the slides were performed following the Agilent hybridization protocol.

scan_protocol: The dried slides were scanned using the GenePix 4100A scanner (Axon Instruments, Downingtown, PA).

data_processing: Image analysis was performed with GenePix Pro 5.1 software and calculated values for all spots were saved as GenePix results files. Data were evaluated using the R software and the limma package from BioConductor. The intensity values were background-corrected with the normexp-method and offset by 1. MA-values were loess-normalized.

molecule: total RNA

organism: Mus musculus

label_protocol: Purified total RNA was amplified and Cy-dye-labeled using the dual-color QuickAmp labeling kit (Agilent, P/N 5190-0444) following the kit instructions. Per reaction, 1 µg of total RNA was used. The samples were labeled with either Cy3 or Cy5 to match a balanced dye-swap design

growth_protocol: MLE12 cells (ATCC) were maintained in DMEM/F12 medium (Gibco) supplemented with 2% fetal bovine serum (FBS, PAA), 10 nM hydrocortisone (Gibco), 10 nM hydro-beta-estradiole (Fischer ICN), 5 µg/ml insulin (PAN Biotech), 10 µg/ml transferrin (PAN Biotech), 30 nM Na-selenite (PAN Biotech), 10 mM HEPES (Sigma), 2 mM L-Glutamine (Gibco) and 1% penicillin/streptomycin (Gibco). A549 cells (ATCC) were maintained in DMEM/F12 medium (Gibco) supplemented with 10% FBS (PAA), 1% vitamins (Gibco), 1% non-essential amino acids (Gibco) and 1% penicillin/streptomycin (Gibco). HEK293T cells (ATCC) and murine fibroblast cell line Mlg (CCL-206, ATCC) were maintained in DMEM medium (Gibco) supplemented with 10% FBS (PAA), 2 mM L-Glutamine (Gibco) and 1% penicillin/streptomycin (Gibco). All cell lines were grown in 10 cm2 tissue culture plates at 37°C, 5% CO2. Cells were seeded and cultured to 60–80% confluency.

extract_protocol: Cells were lysed for RNA isolation 22, 44 and 66 hours after transfection, total RNA was isolated using the RNeasy Plus Mini Kit (Qiagen)

treatment_protocol: MLE12 cells were transfected with expression plasmids pIRES2dsRed2 containing Atf4, Atf6 or spliced Xbp1 cDNA. Transfection with empty vector served as control. For microarray experiments, cells were treated for induction of ER-stress with 1 µM/ml thapsigargin (TG) (Calbiochem).

tag: transfection

tag: tg treatment

value: yes

tag: time [h]


title: E04_Bl001_Cross4757


title: E05_Bl001_Cross4757


title: stimulated_t0.5_3

description:
Array 50 Cy5
Raw data in cy5 channel of: 251486831975_0003.gpr

value: wt

value: no


title: e020_3


title: e040_1


title: unstimulated_t0.5_2

description:
Array 49 Cy5
Raw data in cy5 channel of: 251486831975_0002.gpr


title: e020_2


title: E03_Bl005_Cross4757


title: unstimulated_t0.5_3

description:
Array 50 Cy3
Raw data in cy3 channel of: 251486831975_0003.gpr


title: E05_Bl006_Cross4757


title: E03_Bl001_Cross4757


title: stimulated_t0.5_1

description:
Array 48 Cy5
Raw data in cy5 channel of: 251486831975_0001.gpr


title: stimulated_t0.5_2

description:
Array 49 Cy3
Raw data in cy3 channel of: 251486831975_0002.gpr


title: unstimulated_t1_4

description:
Array 47 Cy3
Raw data in cy3 channel of: 251486831974_0004.gpr


title: stimulated_t0.5_4

description:
Array 51 Cy3
Raw data in cy3 channel of: 251486831975_0004.gpr


title: unstimulated_t0.5_1

description:
Array 48 Cy3
Raw data in cy3 channel of: 251486831975_0001.gpr


title: stimulated_t1_3

description:
Array 46 Cy3
Raw data in cy3 channel of: 251486831974_0003.gpr


title: e020_1


title: unstimulated_t1_3

description:
Array 46 Cy5
Raw data in cy5 channel of: 251486831974_0003.gpr


title: unstimulated_t1_2

description:
Array 45 Cy3
Raw data in cy3 channel of: 251486831974_0002.gpr


title: unstimulated_t1_1

description:
Array 44 Cy5
Raw data in cy5 channel of: 251486831974_0001.gpr


title: starve_3

value: starved


title: stimulated_t1_4

description:
Array 47 Cy5
Raw data in cy5 channel of: 251486831974_0004.gpr


title: E02_Bl002_Cross4757


title: stimulated_t1_2

description:
Array 45 Cy5
Raw data in cy5 channel of: 251486831974_0002.gpr


title: E02_Bl003_Cross4757


title: stimulated_t1_1

description:
Array 44 Cy3
Raw data in cy3 channel of: 251486831974_0001.gpr


title: E03_Bl002_Cross4757

description:
DNA extracted from single blastomere derived from cleavage stage OPU-IVF embryo of pedigree 4757 and subsequently whole genome amplified by Repli-G Single cell kit according to manufacturer's 3h protocol.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: unstimulated_t6_2

description:
Array 41 Cy5
Raw data in cy5 channel of: 251486831973_0002.gpr


title: stimulated_t6_4

description:
Array 43 Cy5
Raw data in cy5 channel of: 251486831973_0004.gpr


title: unstimulated_t6_3

description:
Array 42 Cy5
Raw data in cy5 channel of: 251486831973_0003.gpr


title: stimulated_t6_1

description:
Array 40 Cy5
Raw data in cy5 channel of: 251486831973_0001.gpr


title: stimulated_t6_3

description:
Array 42 Cy3
Raw data in cy3 channel of: 251486831973_0003.gpr


title: unstimulated_t6_1

description:
Array 40 Cy3
Raw data in cy3 channel of: 251486831973_0001.gpr


title: stimulated_t6_2

description:
Array 41 Cy3
Raw data in cy3 channel of: 251486831973_0002.gpr


title: E02_Bl004_Cross4757


title: starve_1


title: E01_Bl006_Cross4757


title: unstimulated_t6_4

description:
Array 43 Cy3
Raw data in cy3 channel of: 251486831973_0004.gpr


title: ATF4.22_rep6

description:
Array 37 Cy5
Raw data in cy5 channel of: 251486829011_0002.gpr


title: E02_Bl001_Cross4757


title: ATF6.22_rep3

description:
Array 38 Cy3
Raw data in cy3 channel of: 251486829011_0003.gpr


title: ATF6.22_rep6

description:
Array 38 Cy5
Raw data in cy5 channel of: 251486829011_0003.gpr


title: Control.44_rep3

description:
Array 39 Cy3
Raw data in cy3 channel of: 251486829011_0004.gpr


title: dsRed.Thaps.44_rep6

description:
Array 35 Cy5
Raw data in cy5 channel of: 251486828776_0004.gpr


title: Control.44_rep6

description:
Array 39 Cy5
Raw data in cy5 channel of: 251486829011_0004.gpr


title: ATF4.22_rep3

description:
Array 37 Cy3
Raw data in cy3 channel of: 251486829011_0002.gpr


title: starve_2


title: ATF6.44_rep3

description:
Array 34 Cy3
Raw data in cy3 channel of: 251486828776_0003.gpr


title: ATF6.44_rep6

description:
Array 34 Cy5
Raw data in cy5 channel of: 251486828776_0003.gpr


title: E01_Bl007_Cross4757

description:
DNA extracted from single blastomere derived from cleavage stage OPU-IVF embryo of pedigree 4757 and subsequently whole genome amplified by Repli-G Single cell kit according to manufacturer's 3h protocol.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: Control.66_rep6

description:
Array 33 Cy5
Raw data in cy5 channel of: 251486828776_0002.gpr


title: dsRed.Thaps.44_rep3

description:
Array 35 Cy3
Raw data in cy3 channel of: 251486828776_0004.gpr


title: E01_Bl003_Cross4757


title: ATF6.22_rep2

description:
Array 32 Cy3
Raw data in cy3 channel of: 251486829010_0004.gpr


title: Control.66_rep3

description:
Array 33 Cy3
Raw data in cy3 channel of: 251486828776_0002.gpr


title: Xbp1.66_rep3

description:
Array 36 Cy3
Raw data in cy3 channel of: 251486829011_0001.gpr


title: Xbp1.66_rep6

description:
Array 36 Cy5
Raw data in cy5 channel of: 251486829011_0001.gpr


title: dsRed.Thaps.44_rep5

description:
Array 31 Cy5
Raw data in cy5 channel of: 251486829010_0003.gpr


title: ATF4.22_rep5

description:
Array 30 Cy5
Raw data in cy5 channel of: 251486829010_0002.gpr


title: E03_Bl003_Cross4757


title: E01_Bl005_Cross4757


title: E01_Bl002_Cross4757


title: ATF4.22_rep2

description:
Array 30 Cy3
Raw data in cy3 channel of: 251486829010_0002.gpr


title: dsRed.Thaps.44_rep2

description:
Array 31 Cy3
Raw data in cy3 channel of: 251486829010_0003.gpr


title: Xbp1.44_rep6

description:
Array 28 Cy5
Raw data in cy5 channel of: 251486829009_0004.gpr


title: Xbp1.44_rep3

description:
Array 28 Cy3
Raw data in cy3 channel of: 251486829009_0004.gpr


title: Control.44_rep5

description:
Array 25 Cy5
Raw data in cy5 channel of: 251486829009_0001.gpr


title: Control.44_rep2

description:
Array 25 Cy3
Raw data in cy3 channel of: 251486829009_0001.gpr


title: ATF4.44_rep6

description:
Array 27 Cy5
Raw data in cy5 channel of: 251486829009_0003.gpr


title: E01_Bl004_Cross4757


title: Control.66_rep2

description:
Array 29 Cy3
Raw data in cy3 channel of: 251486829010_0001.gpr


title: ATF4.44_rep3

description:
Array 27 Cy3
Raw data in cy3 channel of: 251486829009_0003.gpr


title: Xbp1.44_rep5

description:
Array 22 Cy5
Raw data in cy5 channel of: 251486828778_0002.gpr


title: Control.66_rep5

description:
Array 29 Cy5
Raw data in cy5 channel of: 251486829010_0001.gpr


title: Xbp1.44_rep2

description:
Array 22 Cy3
Raw data in cy3 channel of: 251486828778_0002.gpr


title: Xbp1.22_rep3

description:
Array 19 Cy3
Raw data in cy3 channel of: 251486828775_0003.gpr


title: Control.22_rep6

description:
Array 18 Cy5
Raw data in cy5 channel of: 251486828775_0002.gpr


title: dsRed.Thaps.44_rep4

description:
Array 24 Cy5
Raw data in cy5 channel of: 251486828778_0004.gpr


title: ATF6.66_rep3

description:
Array 26 Cy3
Raw data in cy3 channel of: 251486829009_0002.gpr


title: dsRed.Thaps.44_rep1

description:
Array 24 Cy3
Raw data in cy3 channel of: 251486828778_0004.gpr


title: ATF6.66_rep6

description:
Array 26 Cy5
Raw data in cy5 channel of: 251486829009_0002.gpr


title: ATF4.44_rep2

description:
Array 21 Cy3
Raw data in cy3 channel of: 251486828778_0001.gpr


title: ATF4.44_rep5

description:
Array 21 Cy5
Raw data in cy5 channel of: 251486828778_0001.gpr


title: Xbp1.22_rep6

description:
Array 19 Cy5
Raw data in cy5 channel of: 251486828775_0003.gpr


title: ATF6.66_rep5

description:
Array 23 Cy5
Raw data in cy5 channel of: 251486828778_0003.gpr


title: ATF6.22_rep1

description:
Array 20 Cy3
Raw data in cy3 channel of: 251486828775_0004.gpr


title: ATF6.66_rep2

description:
Array 23 Cy3
Raw data in cy3 channel of: 251486828778_0003.gpr


title: ATF4.66_rep6

description:
Array 17 Cy5
Raw data in cy5 channel of: 251486828775_0001.gpr


title: ATF4.66_rep3

description:
Array 17 Cy3
Raw data in cy3 channel of: 251486828775_0001.gpr


title: Xbp1.44_rep4

description:
Array 16 Cy5
Raw data in cy5 channel of: 251486827386_0004.gpr


title: Control.22_rep3

description:
Array 18 Cy3
Raw data in cy3 channel of: 251486828775_0002.gpr


title: ATF6.44_rep5

description:
Array 14 Cy5
Raw data in cy5 channel of: 251486827386_0002.gpr


title: E01_Bl001_Cross4757

description:
DNA extracted from single blastomere derived from cleavage stage OPU-IVF embryo of pedigree 4757 and subsequently whole genome amplified by Repli-G Single cell kit according to manufacturer's 3h protocol.
data structures: The data is provided as five family pedigrees (Cross4757, Cross4006, Cross4770, Cross9617 and Cross8301).


title: ATF6.44_rep2

description:
Array 14 Cy3
Raw data in cy3 channel of: 251486827386_0002.gpr


title: Control.66_rep4

description:
Array 15 Cy5
Raw data in cy5 channel of: 251486827386_0003.gpr


title: Xbp1.44_rep1

description:
Array 16 Cy3
Raw data in cy3 channel of: 251486827386_0004.gpr


title: ATF4.22_rep4

description:
Array 11 Cy5
Raw data in cy5 channel of: 251486827385_0003.gpr


title: Xbp1.22_rep2

description:
Array 13 Cy3
Raw data in cy3 channel of: 251486827386_0001.gpr


title: ATF6.22_rep4

description:
Array 20 Cy5
Raw data in cy5 channel of: 251486828775_0004.gpr


title: Control.44_rep1

description:
Array 12 Cy3
Raw data in cy3 channel of: 251486827385_0004.gpr


title: ATF4.22_rep1

description:
Array 11 Cy3
Raw data in cy3 channel of: 251486827385_0003.gpr


title: Xbp1.66_rep2

description:
Array 10 Cy3
Raw data in cy3 channel of: 251486827385_0002.gpr


title: Control.44_rep4

description:
Array 12 Cy5
Raw data in cy5 channel of: 251486827385_0004.gpr


title: Control.22_rep2

description:
Array 7 Cy3
Raw data in cy3 channel of: 251486827384_0003.gpr


title: ATF6.66_rep4

description:
Array 9 Cy5
Raw data in cy5 channel of: 251486827385_0001.gpr


title: ATF4.66_rep2

description:
Array 8 Cy3
Raw data in cy3 channel of: 251486827384_0004.gpr


title: ATF4.66_rep5

description:
Array 8 Cy5
Raw data in cy5 channel of: 251486827384_0004.gpr


title: ATF6.66_rep1

description:
Array 9 Cy3
Raw data in cy3 channel of: 251486827385_0001.gpr


title: HCC827-RA2-rep2

city: Monterotondo (Roma)

first: Giovina

last: Ruberti

address: Via E. Ramarini, 32

country: Italy

institute: Institute of Cell Biology and Neurobiology, National Research Council

hyb_protocol: Microarray hybridizations were carried out in Agilent’s SureHyb Hybridization Chambers containing 600 ng of Cyanine 3-labelled cRNA per hybridization. The hybridization reactions were performed at 65°C for 17 hours using Agilent’s Gene Expression Hybridization Kit (5188-5242). After hybridization, slides were washed with Agilent Gene Expression Wash Buffer 1, Gene Expression Wash Buffer 2 and Acetonitrile for one minute at room temperature.

scan_protocol: Chips were scanned on an Agilent G2505B scanner. Images were quantified using Agilent Feature Extraction Software (version 10.7.3.1).

data_processing: The raw signal intensity data were background corrected (normexp method) and quantile normalised using limma package of Bioconductor in R program.

source_name: HCC827 derived cell line

label_protocol: 500ng of Poly A+RNA were labelled, using Cyanine 3-CTP  (Perkin Elmer)  with the Agilent Low Imput Linear Amplification Kit and purified with Qiagen’s RNeasy mini spin columns

growth_protocol: The NSCLC cell lines were grown in RPMI 1640 (BioWhittaker, Lonza, USA) supplemented with 10 mM Hepes pH 6.98-7.30, 1 mM L-glutamine, 100 U/ml penicillin/streptomycin (BioWittaker, Lonza) and heat inactivated 10% fetal bovine serum (FBS) (Sigma-Aldrich). All cells were cultured at 37°C in a 5% CO2 humidified incubator.

extract_protocol: Total RNA was isolated using a total RNA purification kit (Norgen Biotek, Thorold, ON, Canada). RNA quantity was determined by absorbance at 260 nm using a NanoDrop ND-1000 UV-VIS spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA). The quality and integrity of each sample were confirmed using a BioAnalyzer. RNA sample replicates for each cell line were labeled and assayed by using SurePrint G3 Human Gene Expression 8x60K v2 (G4851B - 039494) one-color microarray kit of Agilent Technologies. Microarray hybridization was performed according to the Agilent standard protocols.

treatment_protocol: The Erlotinib-resistant NSCLC cell lines were derived by by exposing HCC827 and HCC4006 cell lines (parental) to erlotinib for 5–6 months as previously described (D. Presutti et al,  PLoS One. 2015 Nov 18;10(11):e0143333. doi: 10.1371/journal.pone.0143333. eCollection 2015.)

value: NSCLC

tag: erlotinib response

value: Resistant

tag: tissue


title: ATF6.44_rep1

description:
Array 6 Cy3
Raw data in cy3 channel of: 251486827384_0002.gpr


title: HCC827-RB2-rep2


title: HCC827-rep2

source_name: HCC827 cell line

value: Sensitive


title: Xbp1.66_rep5

description:
Array 10 Cy5
Raw data in cy5 channel of: 251486827385_0002.gpr


title: ATF6.44_rep4

description:
Array 6 Cy5
Raw data in cy5 channel of: 251486827384_0002.gpr


title: HCC4006-rep2

source_name: HCC4006 cell line


title: Xbp1.66_rep4

description:
Array 5 Cy5
Raw data in cy5 channel of: 251486827384_0001.gpr


title: Control.22_rep5

description:
Array 7 Cy5
Raw data in cy5 channel of: 251486827384_0003.gpr


title: HCC4006-RC2.2-rep2

source_name: HCC4006 derived cell line


title: Xbp1.66_rep1

description:
Array 5 Cy3
Raw data in cy3 channel of: 251486827384_0001.gpr


title: HCC827-RB1.1-rep2


title: ATF6.22_rep5

description:
Array 32 Cy5
Raw data in cy5 channel of: 251486829010_0004.gpr


title: HCC827-RA1-rep2


title: HCC827-RB1-rep2


title: Control.22_rep1

description:
Array 3 Cy3
Raw data in cy3 channel of: 251486829012_0003.gpr


title: Control.22_rep4

description:
Array 3 Cy5
Raw data in cy5 channel of: 251486829012_0003.gpr


title: HCC827-RA2-rep1


title: HCC827-rep1


title: HCC4006-RC2.2-rep1


title: Xbp1.22_rep5

description:
Array 13 Cy5
Raw data in cy5 channel of: 251486827386_0001.gpr


title: ATF4.44_rep1

description:
Array 2 Cy3
Raw data in cy3 channel of: 251486829012_0002.gpr


title: HCC4006-rep1


title: HCC827-RB1-rep1


title: Xbp1.22_rep4

description:
Array 1 Cy5
Raw data in cy5 channel of: 251486829012_0001.gpr


title: ATF4.66_rep1

description:
Array 4 Cy3
Raw data in cy3 channel of: 251486829012_0004.gpr


title: HCC827-RA1-rep1


title: HCC827-RB1.1-rep1


title: Subject 143

type: protein

city: Rochester

first: Gregory

middle: A.

last: Poland

state: MN

address: 200 1st St SW

country: USA

institute: Mayo Clinic

description:
raw_data.csv - Sample 147
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.

hyb_protocol: Bound antibodies were detected by incubation with streptavidin-conjugated SureLight® P3 (Columbia Biosciences; Columbia, MD).

scan_protocol: The array slides were scanned using a GenePix® 4300 Microarray Scanner (Molecular Devices; San Diego, CA) and quantified using GenePix® Pro 7 Microarray Acquisition and Analysis Software (Molecular Devices; Sunnyvale, CA) with spot-specific background correction.

data_processing: All samples were run in triplicate against nine proteins/polypeptides and the median values were calculated and normalized for background effects.

label: Biotin

molecule: protein

source_name: Blood - Serum

label_protocol: After the overnight incubation, microarray slides were incubated in Fc������-specific Biotin-SP-Conjugated Affini-Pure Goat Ant-Human IgG secondary Ab (Jackson ImmunoResearch, Inc.; West Grove, PA).

extract_protocol:
Serum samples were diluted 1:100 in Protein Array Blocking Buffer (Whatman, Inc.; Sanford, ME) supplemented with 10% DH5-α Escherichia coli lysate (Antigen Discovery, Inc.), incubated for 30 minutes, and probed on arrays overnight at 4°C. Chips were developed by PCR amplification of cDNA for all rubella virus proteins, as previously described (Davies DH et al., 2005; Luevano M et al., 2010; Kalantari-Dehaghi M et al., 2012). The amplicons were inserted into pXi T7-based exvectors, expressed in coupled in-vitro transcription-translation (IVTT) reactions, and printed onto the microarray slides.
cDNAs were created by RT-PCR from Rubella virus/RV (strain RA27/3, Taxonomy ID) infected cells (total RNAs were extracted using the Qiagen RNeasy Plus mini kit and PCR was performed using the Novagen’s KOD Hot Start DN Polymerase kit/Cat # 71086). The following RV-specific primers were used: for envelope glycoprotein 1/E1 RubE1-F gaggaggctttcacctacctctgca and RubE1-R gcgcggcgctatagcgc; for envelope glycoprotein 2/E2 RubE2-F gggctccagccccgcgct and RubE2-R gccataggcgggggggttgt ; for capsid protein/CP RubC-F atggcttctactacccccatcaccatgga and RubC-R ggcgcgcgcggtgcc ; for nonstructural protein P150 Rub150-F atggagagactcctagatgaggttc and Rub150-R gacagggggaccgcg ; for nonstructural protein P90 RubP90-F cggggcggtggcacc and RubP90-R tagtcagcgtcgtggagattggc. PCR amplicons were verified by sequencing. The amplicons were inserted into pXi T7-based exvectors, and the products were expressed in coupled in-vitro transcription-translation (IVTT) reactions as described previously (Doolan DL et al., Proteomics. 2008 Nov;8(22):4680-94) and printed onto microarray slides as protein/polypeptide spots representing the individual rubella virus proteins/polypeptides. Larger genes (P150 and P90) were amplified in segments overlapping by 150 nucleotides and expressed on the chip as three spots of overlapping polypeptides/fragments for P150 (i.e., P150s1, P150s2, and P150s3), and three spots for P90 (i.e., P90s1, P90s2, and the whole P90). Glycoproteins E1 and E2, and the capsid C protein were expressed on the chip as single spots.

tag: high/low antibody responder to rubella vaccination

value: Low

tag: Sex

value: Male

tag: age

tag: time from last vaccination to  enrollment (years)


title: Subject 144

description:
raw_data.csv - Sample 148
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.

value: Female


title: Subject 140

description:
raw_data.csv - Sample 144
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 142

description:
raw_data.csv - Sample 146
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.

value: High


title: Subject 150

description:
raw_data.csv - Sample 156
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 149

description:
raw_data.csv - Sample 155
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 148

description:
raw_data.csv - Sample 154
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 146

description:
raw_data.csv - Sample 151
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 145

description:
raw_data.csv - Sample 149
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 141

description:
raw_data.csv - Sample 145
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Xbp1.22_rep1

description:
Array 1 Cy3
Raw data in cy3 channel of: 251486829012_0001.gpr


title: Subject 147

description:
raw_data.csv - Sample 153
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: ATF4.44_rep4

description:
Array 2 Cy5
Raw data in cy5 channel of: 251486829012_0002.gpr


title: Subject 139

description:
raw_data.csv - Sample 143
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 134

description:
raw_data.csv - Sample 138
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 138

description:
raw_data.csv - Sample 142
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 137

description:
raw_data.csv - Sample 141
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 135

description:
raw_data.csv - Sample 139
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 136 run 1

description:
raw_data.csv - mean of Sample 140 and Sample 152
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 132

description:
raw_data.csv - Sample 136
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 131

description:
raw_data.csv - Sample 135
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 133

description:
raw_data.csv - Sample 137
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 129

description:
raw_data.csv - Sample 133
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 130

description:
raw_data.csv - Sample 134
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 127

description:
raw_data.csv - Sample 131
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 126

description:
raw_data.csv - Sample 130
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 128

description:
raw_data.csv - Sample 132
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 124

description:
raw_data.csv - Sample 128
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 122

description:
raw_data.csv - Sample 126
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 121 run 1

description:
raw_data.csv - mean of Sample 125 and Sample 150
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 123

description:
raw_data.csv - Sample 127
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 125

description:
raw_data.csv - Sample 129
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 116

description:
raw_data.csv - Sample 120
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 118

description:
raw_data.csv - Sample 122
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 117

description:
raw_data.csv - Sample 121
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 120

description:
raw_data.csv - Sample 124
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 119

description:
raw_data.csv - Sample 123
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 115

description:
raw_data.csv - Sample 119
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 114

description:
raw_data.csv - Sample 118
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 113

description:
raw_data.csv - Sample 117
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 112

description:
raw_data.csv - Sample 116
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 110

description:
raw_data.csv - Sample 114
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 111

description:
raw_data.csv - Sample 115
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 109

description:
raw_data.csv - Sample 113
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 105

description:
raw_data.csv - Sample 109
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 106

description:
raw_data.csv - Sample 110
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 108

description:
raw_data.csv - Sample 112
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 107

description:
raw_data.csv - Sample 111
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 103

description:
raw_data.csv - Sample 107
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 104

description:
raw_data.csv - Sample 108
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 102

description:
raw_data.csv - Sample 106
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 98

description:
raw_data.csv - Sample 102
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 100

description:
raw_data.csv - Sample 104
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 99

description:
raw_data.csv - Sample 103
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Control.66_rep1

description:
Array 15 Cy3
Raw data in cy3 channel of: 251486827386_0003.gpr


title: Subject 95

description:
raw_data.csv - Sample 99
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 97

description:
raw_data.csv - Sample 101
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 92

description:
raw_data.csv - Sample 95
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 89

description:
raw_data.csv - Sample 89
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 93

description:
raw_data.csv - Sample 97
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 87

description:
raw_data.csv - Sample 87
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 94

description:
raw_data.csv - Sample 98
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 91

description:
raw_data.csv - Sample 93
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 86

description:
raw_data.csv - Sample 86
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 88 run 1

description:
raw_data.csv - mean of Sample 88 and Sample 96
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 90

description:
raw_data.csv - Sample 91
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 96

description:
raw_data.csv - Sample 100
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 101

description:
raw_data.csv - Sample 105
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 78

description:
raw_data.csv - Sample 78
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 77

description:
raw_data.csv - Sample 77
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 81

description:
raw_data.csv - Sample 81
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 82

description:
raw_data.csv - Sample 82
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 83

description:
raw_data.csv - Sample 83
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 85

description:
raw_data.csv - Sample 85
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 84

description:
raw_data.csv - Sample 84
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 75

description:
raw_data.csv - Sample 75
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 76

description:
raw_data.csv - Sample 76
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 80

description:
raw_data.csv - Sample 80
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 79

description:
raw_data.csv - Sample 79
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 73 run 1

description:
raw_data.csv - mean of Sample 73 and Sample 94
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 74

description:
raw_data.csv - Sample 74
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 66

description:
raw_data.csv - Sample 66
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 70

description:
raw_data.csv - Sample 70
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 67

description:
raw_data.csv - Sample 67
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 65

description:
raw_data.csv - Sample 65
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 72

description:
raw_data.csv - Sample 72
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 68

description:
raw_data.csv - Sample 68
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 62

description:
raw_data.csv - Sample 62
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 63

description:
raw_data.csv - Sample 63
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 69

description:
raw_data.csv - Sample 69
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 61

description:
raw_data.csv - Sample 61
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 57

description:
raw_data.csv - Sample 57
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 54

description:
raw_data.csv - Sample 54
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 55

description:
raw_data.csv - Sample 55
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 56

description:
raw_data.csv - Sample 56
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 58

description:
raw_data.csv - Sample 58
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 71

description:
raw_data.csv - Sample 71
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 51

description:
raw_data.csv - Sample 51
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 53

description:
raw_data.csv - Sample 53
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 52

description:
raw_data.csv - Sample 52
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 47

description:
raw_data.csv - Sample 47
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 50

description:
raw_data.csv - Sample 50
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 46

description:
raw_data.csv - Sample 46
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 64

description:
raw_data.csv - Sample 64
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 45

description:
raw_data.csv - Sample 45
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 49

description:
raw_data.csv - Sample 49
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 59

description:
raw_data.csv - Sample 59
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 44 run 1

description:
raw_data.csv - mean of Sample 44 and Sample 92
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 43

description:
raw_data.csv - Sample 43
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 41

description:
raw_data.csv - Sample 41
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 48

description:
raw_data.csv - Sample 48
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 40

description:
raw_data.csv - Sample 40
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 42

description:
raw_data.csv - Sample 42
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 38

description:
raw_data.csv - Sample 38
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 35

description:
raw_data.csv - Sample 35
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 39

description:
raw_data.csv - Sample 39
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 34

description:
raw_data.csv - Sample 34
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 33

description:
raw_data.csv - Sample 33
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 29 run 1

description:
raw_data.csv - mean of Sample 29 and Sample 90
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 32

description:
raw_data.csv - Sample 32
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 30

description:
raw_data.csv - Sample 30
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 60

description:
raw_data.csv - Sample 60
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 27

description:
raw_data.csv - Sample 27
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 28

description:
raw_data.csv - Sample 28
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 37

description:
raw_data.csv - Sample 37
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 31

description:
raw_data.csv - Sample 31
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 36

description:
raw_data.csv - Sample 36
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: ATF4.66_rep4

description:
Array 4 Cy5
Raw data in cy5 channel of: 251486829012_0004.gpr


title: Subject 26

description:
raw_data.csv - Sample 26
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 25

description:
raw_data.csv - Sample 25
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.


title: Subject 24

description:
raw_data.csv - Sample 24
Serum samples were run in triplicate against rubella nine rubella virus proteins/polypeptides (i.e., E1, E2, and C rubella virus proteins, three spots of overlapping polypeptides/fragments for P150 [i.e., P150s1, P150s2, and P150s3], and three spots for P90 [i.e., P90s1, P90s2, and the whole P90] on the proteome microarray chip (Antigen Discovery, Inc., Irvine, CA). No DNA(expressed protein) spots were used for negative control for each serum sample.